首页> 外文期刊>Journal of clinical laboratory analysis. >Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection
【24h】

Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection

机译:结核分枝杆菌分泌的蛋白质作为诊断活动性肺结核和潜伏性结核感染的潜在生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The detection of Mycobacterium tuberculosis (Mtb) specific human antibodies has been an important diagnostic aid in the diagnosis of tuberculosis (TB) cases with smear-negative sputum samples, especially for the screening of high-risk population. This study focused on the analysis and comparison of the four potential Mtb-secreted proteins (ESAT6, CFP10, Ag85B, Hsp16.3) and the fusion protein Ag85B-Hsp16.3 as new markers in the serodiagnosis between active TB and latent TB infection (LTBI). Methods: These five recombinant proteins were produced and used in optimized ELISA to detect IgG serum antibodies against the four secreted proteins. The capacity of identifying infection was evaluated either in active TB patients or LTBI individuals, which was compared with the control groups consisting of hospitalized non-TB individuals. Results: The results showed that Ag85B-Hsp16.3/ESAT6 and Hsp16.3/ESAT6 were the best-associated antigens for serology diagnosis of the active TB and LTBI individuals because of their specificity, sensitivity, YI values, and positive rates, respectively. ELISA test demonstrated that 41.67% (25/60) of blood donors respond to Ag85B-Hsp16.3/ESAT6. The consistency of this positive respond with clinical diagnosis almost reached 84% (21/25). Conclusion: Thus, a combined test of multiple Mtb-secreted proteins Ag85B, Hsp16.3, and ESAT6 may be the ascendant preliminary screening antigens for active TB or LTBI patients. (C) 2014 The Authors. Journal of Clinical Laboratory Analysis. Published by Wiley Periodicals, Inc.
机译:背景:结核分枝杆菌(Mtb)特异性人类抗体的检测已成为诊断痰涂片阴性的结核病(TB)的重要诊断手段,尤其是对高危人群的筛查。这项研究的重点是分析和比较四种潜在的Mtb分泌蛋白(ESAT6,CFP10,Ag85B,Hsp16.3)和融合蛋白Ag85B-Hsp16.3作为活动性结核病和潜伏性结核感染之间血清学诊断的新标志LTBI)。方法:产生了这五种重组蛋白,并用于优化ELISA中以检测针对这四种分泌蛋白的IgG血清抗体。在活动性结核病患者或LTBI个体中评估了识别感染的能力,并将其与由住院的非结核性个体组成的对照组进行了比较。结果:结果表明,Ag85B-Hsp16.3 / ESAT6和Hsp16.3 / ESAT6由于其特异性,敏感性,YI值和阳性率分别是用于活动性结核病和LTBI个体血清学诊断的最佳相关抗原。 。 ELISA试验表明,有41.67%(25/60)的献血者对Ag85B-Hsp16.3 / ESAT6有反应。这种阳性反应与临床诊断的一致性几乎达到84%(21/25)。结论:因此,多种Mtb分泌蛋白Ag85B,Hsp16.3和ESAT6的组合测试可能是针对活动性TB或LTBI患者的初步筛选抗原。 (C)2014作者。临床实验室分析杂志。由Wiley Periodicals,Inc.发布

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号